MEI Pharma Inc (MEIP)
2.875
-0.04
(-1.54%)
USD |
NASDAQ |
Nov 18, 16:00
2.89
+0.02
(+0.52%)
After-Hours: 20:00
MEI Pharma Price: 2.875 for Nov. 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2024 | 2.916 | 2.997 | 2.85 | 2.875 | 21470.00 |
| Nov 15, 2024 | 2.98 | 3.01 | 2.854 | 2.92 | 33863.00 |
| Nov 14, 2024 | 2.98 | 3.10 | 2.98 | 3.01 | 12904.00 |
| Nov 13, 2024 | 3.08 | 3.15 | 3.03 | 3.03 | 13548.00 |
| Nov 12, 2024 | 3.136 | 3.14 | 3.08 | 3.14 | 12047.00 |
| Nov 11, 2024 | 3.05 | 3.15 | 3.05 | 3.13 | 13875.00 |
| Nov 08, 2024 | 2.96 | 3.10 | 2.90 | 3.04 | 14829.00 |
| Nov 07, 2024 | 3.04 | 3.125 | 3.00 | 3.03 | 23619.00 |
| Nov 06, 2024 | 3.07 | 3.10 | 2.990 | 3.04 | 63083.00 |
| Nov 05, 2024 | 3.06 | 3.10 | 3.01 | 3.04 | 6712.00 |
| Nov 04, 2024 | 3.10 | 3.13 | 2.98 | 3.06 | 11591.00 |
| Nov 01, 2024 | 3.00 | 3.10 | 3.00 | 3.07 | 14358.00 |
| Oct 31, 2024 | 3.05 | 3.11 | 3.00 | 3.10 | 40657.00 |
| Oct 30, 2024 | 3.16 | 3.29 | 3.03 | 3.11 | 39822.00 |
| Oct 29, 2024 | 3.00 | 3.17 | 2.94 | 3.17 | 105992.0 |
| Oct 28, 2024 | 2.95 | 3.213 | 2.80 | 3.085 | 553086.0 |
| Oct 25, 2024 | 2.727 | 2.74 | 2.725 | 2.73 | 1.025M |
| Oct 24, 2024 | 2.715 | 2.755 | 2.705 | 2.735 | 11345.00 |
| Oct 23, 2024 | 2.80 | 2.80 | 2.72 | 2.74 | 3406.00 |
| Oct 22, 2024 | 2.75 | 2.79 | 2.75 | 2.75 | 18756.00 |
| Oct 21, 2024 | 2.785 | 2.785 | 2.704 | 2.74 | 13220.00 |
| Oct 18, 2024 | 2.70 | 2.80 | 2.685 | 2.77 | 25674.00 |
| Oct 17, 2024 | 2.74 | 2.80 | 2.683 | 2.75 | 12284.00 |
| Oct 16, 2024 | 2.70 | 2.800 | 2.70 | 2.77 | 5872.00 |
| Oct 15, 2024 | 2.694 | 2.75 | 2.65 | 2.71 | 40432.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.67
Minimum
Oct 14 2024
90.00
Maximum
Feb 08 2021
29.35
Average
11.38
Median
Price Benchmarks
| Avid Bioservices Inc | 12.16 |
| Evoke Pharma Inc | 4.37 |
| Revance Therapeutics Inc | 3.99 |
| NovaBay Pharmaceuticals Inc | 0.6998 |
| Palatin Technologies Inc | 0.95 |
Price Related Metrics
| PE Ratio | 1.082 |
| PS Ratio | 0.1827 |
| Price to Book Value | 0.5831 |
| Earnings Yield | 92.39% |
| Market Cap | 19.26M |
| Operating PE Ratio | 0.5242 |
| Normalized PE Ratio | 0.4728 |